Arkis BioSciences® is a medical device company providing sophisticated surgical tools and implantables for advancing the neurosurgical treatments of intracranial hypertension arising from hydrocephalus, traumatic brain injury, and hemorrhagic stroke. In 2016, Arkis introduced its Single Pass Tunneling GuidewireTM as well as the Subcutaneous GuidewireTM. In 2017, Arkis introduced the next generation CerebroFloTM EVD Catheter which incorporates Endexo® polymer technology. Located in Knoxville, Tennessee, Arkis began operations in 2013 to serve the neurosurgical market to improve intracranial hypertensive patient care while reducing healthcare costs.
Advancing medical technology worldwide to improve the lives of people suffering from intracranial hypertension.